XORBAC CLINDAMYCIN AND BENZOYL PEROXIDE GEL 1%/5% [SIN17607P]
Active ingredients: CLINDAMYCIN PHOSPHATE EQUIVALENT TO CLINDAMYCIN | HYDROUS BENZOYL PEROXIDE EQUIVALENT TO BENZOYL PEROXIDE
Product Info
XORBAC CLINDAMYCIN AND BENZOYL PEROXIDE GEL 1%/5%
[SIN17607P]
Product information
Active Ingredient and Strength | CLINDAMYCIN PHOSPHATE EQUIVALENT TO CLINDAMYCIN - 1% |
Dosage Form | GEL |
Manufacturer and Country | ENCUBE ETHICALS PRIVATE LIMITED - INDIA |
Registration Number | SIN17607P |
Licence Holder | GOLDPLUS UNIVERSAL PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | D10AF51 |
Prescription-only Medicines with Exemptions for Supply without Prescription | As a topical preparation not exceeding 1%
|
Indication
INDICATION
XORBAC (Clindamycin and Benzoyl Peroxide Gel, 1% / 5%) is indicated for the topical treatment of mild to moderate acne vulgaris.
XORBAC (Clindamycin and Benzoyl Peroxide Gel, 1% / 5%) has not been demonstrated to have any additional benefit when compared to benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne.
Dosing
DOSAGE AND ADMINISTRATION
Adults and Adolescents
XORBAC (Clindamycin and Benzoyl Peroxide Gel, 1% / 5%) is for topical use only.
XORBAC (Clindamycin and Benzoyl Peroxide Gel, 1% / 5%) should be applied in a thin film over entire affected area once daily after washing gently with a mild cleanser and fully drying.
If the gel does not rub into the skin easily, too much is being applied.
Hands should be washed after application.
Patients may also use a moisturiser as needed.
Two to five weeks of treatment may be required before a therapeutic effect is observed.
The safety and efficacy of clindamycin/benzoyl peroxide have not been studied beyond 12 weeks in acne vulgaris clinical trials. The prescriber should evaluate the benefit of continuing treatment beyond 12 weeks of uninterrupted use.
Children
The safety and efficacy of Clindamycin and Benzoyl Peroxide Gel, 1%/ 5% have not been established in children less than 12 years of age, therefore clindamycin/benzoyl peroxide is not recommended for use in this population.
Elderly
There are no specific recommendations for use in the elderly.
Contraindications
CONTRAINDICATION
XORBAC is contraindicated in:
patients who have demonstrated hypersensitivity to lincomycin, clindamycin, benzoyl peroxide or any components of the formulation.
patients with, or with a history of regional enteritis, ulcerative colitis, or antibiotic associated colitis (including pseudomembranous colitis).
